Primary biliary cholangitis (PBC) is the most common of the autoimmune liver diseases, with
a female predominance and prevalence that varies greatly geographically with reports of 19 …

Background and aims Current treatment guidelines recommend ursodeoxycholic acid
(UDCA) as the first-line treatment for new-diagnosed primary biliary cholangitis (PBC) …

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease. The management
landscape was transformed 20 years ago with the advent of ursodeoxycholic acid. Up to …

Primary biliary cholangitis (PBC), previously referred to as primary biliary cirrhosis, is a
progressive cholestatic liver disease characterized by the destruction of small intrahepatic …

METHODS: Ursodeoxycholic acid–treated patients from 7 centers participating in the
GLOBAL PBC Study Group were included. The discriminatory performance of the scores …

Primary biliary cholangitis is a chronic, seropositive and female-predominant inflammatory
and cholestatic liver disease, which has a variable rate of progression towards biliary …

Introduction and objectives Little is known about primary biliary cholangitis (PBC) in non-
whites. The purpose of this study was to evaluate clinical features and outcomes of PBC in a …

Introduction: primary biliary cholangitis (PBC) is a rare disease with limited data regarding its
epidemiology and standard clinical management in Spain. Objective: to gain insight into the …

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, 1 is an
autoimmune liver disease characterized by circulating anti-mitochondrial antibodies (AMA) …

Primary biliary cholangitis (PBC), formerly called primary biliary cirrhosis, is a chronic
cholestatic disease characterized by an autoimmune-mediated destruction of small and …